Amryt Pharma plc (AMYT) | Stock Overview & Key Data
Amryt Pharma plc Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $14.71 on January 16, 2025
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Amryt Pharma plc
AMYT
|
N/A | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | N/A | N/A | N/A | N/A | N/A | N/A |
|
AcelRx
ACRX
|
12.24M Micro-cap | -8.90% | 22.02% | 66.25% | 33.00% | 14.66% | 77.55% | -26.27% | -96.87% | -98.48% | -98.97% | -99.04% |
|
Eli Lilly and
LLY
|
821.31B Mega-cap | -1.72% | 12.38% | 14.18% | 6.32% | 4.53% | 38.28% | 153.07% | 418.42% | 1,433.98% | 2,935.09% | 1,988.48% |
| 555.84B Mega-cap | 1.51% | 3.95% | -3.10% | 10.03% | 13.65% | 53.32% | 46.67% | 48.70% | 108.58% | 263.36% | 290.52% | |
|
AbbVie
ABBV
|
351.47B Mega-cap | 2.58% | 8.40% | 22.13% | 18.90% | 10.98% | 19.18% | 64.26% | 101.32% | 279.49% | 590.09% | 590.09% |
|
UnitedHealth
UNH
|
322.34B Mega-cap | 1.10% | 4.36% | 43.98% | 20.50% | 22.19% | 30.30% | -10.90% | 4.92% | 196.70% | 717.69% | 822.38% |
Ownership & Short Interest
Calculate Your Amryt Pharma plc Investment Returns
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is AMYT's 52-week high and low?
- In the last 52 weeks, Amryt Pharma plc reached a high of $14.71 (on January 16, 2025) and a low of $14.70 (on January 16, 2025).
- What is the market cap and P/E ratio for AMYT?
- Curious about Amryt Pharma plc's size and valuation? Its market capitalization stands at N/A. When it comes to valuation, the P/E ratio (trailing twelve months) is 39.73, and the forward P/E (looking ahead) is -490.00.
- Does AMYT pay dividends? If so, what's the yield?
- As for dividends, Amryt Pharma plc isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Amryt Pharma plc's main competitors or similar companies to consider before investing?
When looking at Amryt Pharma plc, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return AcelRx
ACRX12.24M Healthcare Drug Manufacturers—Specialty & Generic 77.55% -26.27% Eli Lilly and
LLY821.31B Healthcare Drug Manufacturers - General 38.28% 153.07% Johnson & Johnson
JNJ555.84B Healthcare Drug Manufacturers - General 53.32% 46.67% AbbVie
ABBV351.47B Healthcare Drug Manufacturers - General 19.18% 64.26% UnitedHealth
UNH322.34B Healthcare Healthcare Plans 30.30% -10.90% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Amryt Pharma plc? (e.g., ROE, Debt/Equity)
- To get a sense of Amryt Pharma plc's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -94.18%, the Debt to Equity ratio from the most recent quarter is 164.32, and its Gross Profit Margin stands at 44.86%.
- What is the recent revenue and earnings growth for AMYT?
- Looking at Amryt Pharma plc's growth, its revenue over the trailing twelve months (TTM) was $223M. Compared to the same quarter last year (YoY), quarterly revenue grew by -10.81%, and quarterly earnings saw a YoY growth of N/A.
- How much of AMYT stock is held by insiders and institutions?
- Wondering who owns Amryt Pharma plc stock? Company insiders (like executives and directors) hold about N/A of the shares, while institutional investors (such as mutual funds and pension funds) own approximately N/A.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.